Swellable dosage form comprising gellan gum

Abstract

A novel dosage form. The dosage form is presented in particulate form and before oral ingestion the particulate material is subjected to an aqueous medium, whereby it is converted to a semi-solid form by swelling or gelling of one or more of the components, especially of a gellan gum, of the particulate matter. The invention also relates to a vehicle for oral administration of one or more active substances, the vehicle comprising a gellan gum arranged in a configuration allowing optimal water diffusion so that upon addition of a predetermined amount of an aqueous medium, without the necessity of applying shear forces or other mixing forces, within a time period of 5 minutes or less swells and / or gels and the texture of the swelled vehicle being similar to that of a soft pudding and having a viscosity of at least about 10,000 cps as measured by a Brookfield Viscometer with a #4 LV spindle at 6 rpm and at 20-25° C. In one embodiment of the invention, the particulate matter can be molded into a desired shape or pressed onto a dispensing unit such as a spoon.

Description

FIELD OF THE INVENTION[0001]The present application relates to a novel dosage form. The dosage form is presented in particulate form and before oral ingestion the particulate material is subjected to an aqueous medium, whereby it is converted to a semi-solid form by swelling or gelling of one or more of the components, especially of a gellan gum, of the particulate matter. The invention also relates to a vehicle for oral administration of one or more active substances, the vehicle comprising a gellan gum arranged in a configuration allowing optimal water diffusion so that upon addition of a predetermined amount of an aqueous medium, without the necessity of applying shear forces or other mixing forces, within a time period of 5 minutes or less swells and / or gels and the texture of the swelled vehicle being similar to that of a soft pudding and having a viscosity of at least about 10,000 cps as measured by a Brookfield Viscometer with a #4 LV spindle at 6 rpm and at 20-25 ° C.[0002]I...

AI Technical Summary

Benefits of technology

[0020]The pharmaceutical composition and the dispensing unit according to the invention are intended to be contacted with a small amount of water before administration and the water induces the swelling of the gellan gum, which makes the composition easy to ingest and at the same time provides an acceptable mouth-feel.

[0141]Although it is not required, it is preferred that the API, gellan gum, hydro gel(s), and excipients is in particulate form. The particles should, as a general rule, be of a size, such that, the matrix can hydrate sufficiently, and equally throughout the matrix. To prevent segregation, and consequently inhomogen products it would be preferable to formulate with uniform particle sizes, with exception of PVP, wherein it can also be an advantage to have smaller particles. A suitable granular size should be between 350-500 μm. Furthermore it is an advantage to seal the material after fastened the discrete units on a delivering device. The fastening is easily done by spraying the device with a glue to adhere the discrete unit to the device. Such glue may be produced by mixing a volatile liquid with a binder until a clear solution is achieved, and the formulation is transferred to e.g. by use of an aerosol can to the device, such as a spoon the volatile liquid is evaporated from the spoon in an oven, and thus the device surface is sticky.

Problems solved by technology

A recurring problem in the treatment of patients, in particular children and the elderly, is their inability or unwillingness to swallow solid oral dosage forms such as tablets or capsules.

The problem is, however, not uncommon in healthy adults as well.

This problem is not trivial, the inability or unwillingness of some people to take solid oral dosage forms can severely compromise the patient's compliance with a prescribed treatment protocol.

Moreover, due to embarrassment, many patients are unwilling to tell their doctor of their problem so that the doctor can consider other drugs and / or alternate dosage forms.

Such a lack of compliance can compromise treatment or cure.

Unfortunately, in many cases the native taste of the drug is unpleasant and not amenable to taste-masking by the addition of sweeteners of flavours.

Also, many drugs have such pharmacokinetic parameters that demand administration at short intervals, disrupting sleep and other activities.

The monolithical units are often unacceptable to people having the swallowing problems described above.

Finally, some substances are administered in such high doses that the resulting tablets or capsules are either very large or that many tablets or capsules must be administered simultaneously, in either case, causing discomfort.

Those tablets and capsules as such are inappropriate for patients with swallowing difficulties.

This approach has limitations.

The carrier (syrup, pudding, applesauce) is not a well defined entity and different carriers might interact differently with the multi-particles and / or drug and thereby compromise the treatment.

Also, children might object to the grittiness in the material.

Often, these dosage forms leave an objectionable deposit in the glass, which may represent a non-ingested part of the drug.

However, the effervescence on the tongue may be unpleasant to some adults and to many children.

Images